Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2026-01-07 @ 7:31 PM
Study NCT ID:
NCT00069095
Status:
COMPLETED
Last Update Posted:
2016-10-06
First Post:
2003-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2006-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2003-09-15
First Submit QC Date:
None
Study First Post Date:
2003-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-11
Results First Submit QC Date:
None
Results First Post Date:
2016-01-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-26
Last Update Post Date:
2016-10-06
Last Update Post Date Type:
ESTIMATED